Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2010

3645 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson's disease.

Keyser RJ, Lesage S, Brice A, Carr J, Bardien S.

Biochem Biophys Res Commun. 2010 Jul 16;398(1):125-9. doi: 10.1016/j.bbrc.2010.06.049.

0

0

0

PUBMED

Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.

Oulis P, Mourikis I, Konstantakopoulos G, Papageorgiou SG, Kouzoupis AV.

J Neuropsychiatry Clin Neurosci. 2010 Summer;22(3):352c.e4-352.e5. doi: 10.1176/appi.neuropsych.22.3.352-c.e4. No abstract available.

0

0

0

PUBMED

Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.

Callaghan RC, Cunningham JK, Sajeev G, Kish SJ.

Mov Disord. 2010 Oct 30;25(14):2333-9. doi: 10.1002/mds.23263.

0

0

0

PUBMED

Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.

Taherzadeh-Fard E, Saft C, Wieczorek S, Epplen JT, Arning L.

Neurogenetics. 2010 Oct;11(4):435-9. doi: 10.1007/s10048-010-0248-3.

0

0

0

PUBMED

Impaired step up/over in persons with Parkinson's disease.

Nocera JR, Horvat M, Ray CT.

Adapt Phys Activ Q. 2010 Apr;27(2):87-95.

0

0

0

PUBMED

Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.

Hands SL, Mason R, Sajjad MU, Giorgini F, Wyttenbach A.

Biochem Soc Trans. 2010 Apr;38(2):552-8. doi: 10.1042/BST0380552.

0

0

0

PUBMED

Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis.

Capelle HH, Blahak C, Schrader C, Baezner H, Kinfe TM, Herzog J, Dengler R, Krauss JK.

Mov Disord. 2010 Jul 30;25(10):1477-81. doi: 10.1002/mds.23123.

0

0

0

PUBMED

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.

Lopes FM, Schröder R, da Frota ML Jr, Zanotto-Filho A, Müller CB, Pires AS, Meurer RT, Colpo GD, Gelain DP, Kapczinski F, Moreira JC, Fernandes Mda C, Klamt F.

Brain Res. 2010 Jun 14;1337:85-94. doi: 10.1016/j.brainres.2010.03.102.

0

0

0

PUBMED

Hearts of dystonia musculorum mice display normal morphological and histological features but show signs of cardiac stress.

Boyer JG, Bhanot K, Kothary R, Boudreau-Larivière C.

PLoS One. 2010 Mar 1;5(3):e9465. doi: 10.1371/journal.pone.0009465.

0

0

0

PUBMED

Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder.

Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE.

Psychosomatics. 2010 Mar-Apr;51(2):124-9. doi: 10.1176/appi.psy.51.2.124.

0

0

0

PUBMED

Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.

Ohnuki T, Nakamura A, Okuyama S, Nakamura S.

Brain Res. 2010 Jul 30;1346:26-42. doi: 10.1016/j.brainres.2010.05.066.

0

0

0

PUBMED

Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients.

Maia FM, Kanashiro AK, Chien HF, Gonçalves LR, Barbosa ER.

Parkinsonism Relat Disord. 2010 Jan;16(1):8-11. doi: 10.1016/j.parkreldis.2009.06.004.

0

0

0

PUBMED

Movement disorders and pregnancy: a review of the literature.

Kranick SM, Mowry EM, Colcher A, Horn S, Golbe LI.

Mov Disord. 2010 Apr 30;25(6):665-71. doi: 10.1002/mds.23071. Review.

0

0

0

PUBMED

Association of the human leucocyte antigen region with susceptibility to Parkinson's disease.

Saiki M, Baker A, Williams-Gray CH, Foltynie T, Goodman RS, Taylor CJ, Compston DA, Barker RA, Sawcer SJ, Goris A.

J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):890-1. doi: 10.1136/jnnp.2008.162883.

0

0

0

PUBMED

Gabapentin enacarbil: pharmacotherapy of restless legs syndrome.

Jones R, Rickards H, Cavanna AE.

J Cent Nerv Syst Dis. 2010 Nov 23;2:45-55. doi: 10.4137/JCNSD.S4886.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy